Evaluation of CUDECA Cui-DAR Plan in People With Oncological and Non-oncological Diseases in the Last Days of Their Lives (CUIDARCUDECA)

NCT07446673 | Completed

• 1 other identifier: CUDECA FOUNDATION
• Study Type: observational
• Target: 348
• Locations: 1 country
• Sites: 3

Brief Summary

Cudeca, an independent non-profit organization located in Malaga (Spain), treats patients with advanced and terminal disease. It has developed Cui-DAR Cudeca plan, a care plan for the care of patients in situations of last days of thier live that integrates in a single document, all the assessments and multidisciplinary actions necessary, from the beginning of last days situation, to the care after death. The objective of the study is to evaluate the validity and effectiveness of the Cui-DAR CUDECA Plan in people in a situation of last days compared to conventional care in the assessment of symptoms and signs.

Conditions

Patients in Situation of Last Days of Their Life; Oncological and no Onoclogical Disease

Keywords

palliative care, last days of live, care plan; sympton control

Outcome Measures

Primary Outcomes (1)

• Number of patients with oncological and non-oncological diseases who are at the end of their lives and have been evaluated with the CUDECA Cui-DAR Plan for the care of symptoms and signs.

  Patients with oncological and non-oncological diseases who die in the Cudeca Foundation Hospitalisation Unit attended with the CUi-DAR Cudeca Plan.

  Through study completion, an average of 12 months

Secondary Outcomes (4)

• Number of patients with oncological and non-oncological diseases who has individualised care plans in the last days of life.

  Through study completion, an average of 3 months

• Number of patients with oncological and non-oncological diseases who are at the end of their lives and have been given an advance prescription for medication.

  Through study completion, an average of 3 months

• Number of patients with oncological and non-oncological diseases with daily assessment of hydration at the end of life

  Through study completion, an average of 3 months

• Number of bereaved relatives of patients with cancer and non-cancer diseases who feel satisfied that the deceased person received support to drink or receive fluids if they so desired.

  Through study completion, an average of 3 months

Other Outcomes (2)

• Age

  Baseline

• Sex

  Baseline

Study Arms (3)

Patients who died in the Hospitalization Unit of the Cudeca Foundation (Benalmádena, Málaga,Spain)

Patients in the last days of their illness who die treated in Cudeca,s Inpatient Unit attended with a specific care plan at this situation (Cui-DAR CUDECA Plan)

Other: Care Plan Cui-dar CUdeca

Patients who died in the Catalan Institute of Oncology hospital (Barcelona, Spain)

Patients in the last days of their illness who die treated in the Inpatient Unit of Catalan Institute of Oncology (L'Hospitalet de Llobregat ,Barcelona, España). No intervention.

Patients who died in the Inpatient Unit of San Juan de Dios Hospital (Pamplona, Navarra, Spain)

Patients in the last days of their illness who die treated in he Inpatient Unit of San Juan de Dios hospital (Pamplona, Navarra, Spain). No intervention.

Interventions

Care Plan Cui-dar CUdeca OTHER

Attend to the patient in the last days of their life with the CUi-DAR care plan

Patients who died in the Hospitalization Unit of the Cudeca Foundation (Benalmádena, Málaga,Spain)

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Patients in the last days of life

You may qualify if:

• Acceptance to participate in the study by signing the informed consent.
• Patients in the last days of life who die in Cudeca Foundation and who was cared under Cui-DAR Cudeca Plan during data collection period.
• Patients in the last days of life who die in others Palliative care Units Cudeca Foundation and who was cared under Cui-DAR Cudeca Plan durging data collection period.

You may not qualify if:

• No acceptance to participate in the study by signing the informed consent.
• Patients in the last days of life who die in Cudeca Foundation and who wasn,t cared under Cui-DAR Cudeca Plan during data collection period.
• Pacients

Sponsors & Collaborators

• Cudeca Hospice Foundation: lead

Study Sites (3)

Instituto Catalan de Oncología

Barcelona, Barcelona, Spain

Location

Fundación CUDECA

Benalmádena, Málaga, 29631, Spain

Location

Hospital San Juan de Dios

Pamplona, Navarre, Spain

Location

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Target Duration: 3 Days
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 15, 2025
• First Posted: March 3, 2026
• Study Start: January 27, 2022
• Primary Completion: January 30, 2026
• Study Completion: February 20, 2026
• Last Updated: March 3, 2026

Record last verified: 2025-11

Locations

ES (3)